HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Use of imipenem-cilastatin in neonatal septicemias caused by gram-negative bacilli multiresistant to beta-lactam antibiotics].

Abstract
Seven neonates with septicemia due to Gram negative bacteria resistant to beta-lactam received imipenem-cilastatin therapy. Bacteria isolated were Enterobacter cloacae [3], Enterobacter aerogenes [1], Klebsiella pneumoniae [1], Serratia marcescens [1], Pseudomonas fluorescens [1]. The MICs of imipenem were lower 1 microgram/ml. In 3 children septicemia occurred during previous antimicrobial chemotherapy. 3 IV 60 mg/kg doses of imipenem with amikacin (15 mg kg/d) were administered every day. For five children blood cultures were negative after 48 hours of treatment. E. aerogenes septicemia required pefloxacin because blood cultures remained positive (d5) despite an increased dosage (90 mg/kg/d). All children were cured and imipenem-cilastatin was not responsible for any complication. Those results demonstrate the efficacy of imipenem in the treatment of septicemia in newborns due to multiresistant Gram negative bacteria.
AuthorsY Bompard, T Lambert, A Gantzer, A Chastel, A Voinnesson, C Aufrant
JournalPathologie-biologie (Pathol Biol (Paris)) Vol. 36 Issue 5 Pg. 521-4 (May 1988) ISSN: 0369-8114 [Print] France
Vernacular TitleUtilisation de l'imipénème-cilastatine dans les septicémies du nouveau-né à bacilles Gram négatif multirésistants aux bêtalactamines.
PMID3043351 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Cyclopropanes
  • Thienamycins
  • Cilastatin
  • Imipenem
Topics
  • Anti-Bacterial Agents (pharmacology)
  • Cilastatin
  • Cyclopropanes (administration & dosage, pharmacology)
  • Drug Evaluation
  • Drug Resistance, Microbial
  • Drug Therapy, Combination
  • Enterobacteriaceae (drug effects)
  • Enterobacteriaceae Infections (drug therapy)
  • Humans
  • Imipenem
  • Infant, Newborn
  • Infant, Premature, Diseases (drug therapy)
  • Sepsis (drug therapy)
  • Thienamycins (administration & dosage, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: